ArticleACS medicinal chemistry letters2019

Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents.

Antonio Coluccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.